Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
Pharmabiz
3h
AstraZeneca’s Calquence plus chemoimmunotherapy approved in US for patients with previously untreated mantle cell lymphoma
AstraZeneca’s Calquence plus chemoimmunotherapy approved in US for patients with previously untreated mantle cell lymphoma: Cambridge, UK Monday, January 20, 2025, 09:00 Hrs [IS ...
10h
Biden adds weight loss drugs to Medicare price negotiations
Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
Israel frees 90 prisoners
Posthumously pardoned
DOJ sues Walgreens
Court declares DACA illegal
Draft lyrics sell for $508K
Rapper charged with assault
Judge denies bail ruling
Georgia halts poultry sales
Resentencing date pushed
Falcons hire Ulbrich as DC
2 Iranian judges shot dead
Deputy education secretary
Begins restoring service
OR man gets life sentence
US drops corruption case
Crosses $1 billion globally
Fed exits climate group
Suspends drone deliveries
Ex-CIA analyst pleads guilty
Russia attacks Kyiv
Nigeria tanker explosion
Denied bail in assault case
Liable for defaming veteran
US winter storm warnings
FTC sues PepsiCo
Victory rally in Washington
NHTSA probing GM vehicles
Related topics
AstraZeneca
United States
Mantle cell lymphoma
Medicare
Food and Drug Administration
Feedback